NCT04218812

Brief Summary

Electrical source imaging is part of the presurgical evaluation of patients with drug-resistant focal epilepsy. The software packages that will be used in this study have Declaration of Conformity within the European Economic Area (CE mark) for this specific medical use. In spite of being part of the clinical standard, the evidence for the accuracy and clinical utility of these methods are derived from several smaller-scale and retrospective studies. The PROMAESIS study will provide solid evidence of the accuracy and clinical utility of automated ESI.

Trial Health

62
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
8 countries

12 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 12, 2019

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 30, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 6, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
3.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 2, 2024

Status Verified

February 1, 2024

Enrollment Period

2.1 years

First QC Date

December 30, 2019

Last Update Submit

February 1, 2024

Conditions

Keywords

SensitivitySpecificityAccuracyAutomated ESIRefractory epilepsyEpilepsy surgeryClinical Utility

Outcome Measures

Primary Outcomes (2)

  • The Sensitivity and Specificity of automated ESI in presurgical evaluation.

    For determining the the accuracy (sensitivity and specificity) of automated ESI, one year outcome after the operation will be calculated based on the defined criteria. * True Positive (TP): source is in the same sub-lobar region as the resection, seizure-free outcome * False Positive (FP): source is in the same sub-lobar region as the resection, not seizure-free outcome * True Negative (TN): source outside the sub-lobar region that was resected, not seizure-free outcome * False Negative (FN): source outside the sub-lobar region that was resected, seizure-free outcome.

    2 Years

  • the clinical utility of ESI in management of the patient with medically refractory epilepsy

    For determining the clinical utility, the percentage of patients in whom automated ESI change decision on patients management will be calculated.

    2 years

Study Arms (2)

No electrical source imaging (ESI)

ACTIVE COMPARATOR

The multidisciplinary teams take decisions based on considering all data without ESI

Diagnostic Test: No electrical source imaging (ESI)Diagnostic Test: Automated electrical source imaging (ESI)

Automated Electrical source imaging (ESI)

EXPERIMENTAL

The multidisciplinary teams take decisions based on considering all data with ESI

Diagnostic Test: No electrical source imaging (ESI)Diagnostic Test: Automated electrical source imaging (ESI)

Interventions

For all patients: MRI, semiology, visual interpretation of EEG, and in selected cases, PET, SPECT

Automated Electrical source imaging (ESI)No electrical source imaging (ESI)

The automated source imaging consists of 2 phases 1. Automated detection of EDs 2. Source imaging of each spike cluster and seizure onset epoch.

Automated Electrical source imaging (ESI)No electrical source imaging (ESI)

Eligibility Criteria

Age1 Year - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with drug resistant focal epilepsy, admitted to Epilepsy Monitoring Unit for presurgical evaluation, who are afterwards discussed at the multidisciplinary epilepsy surgery team meetings.

You may not qualify if:

  • Patients who did not have a seizure during the monitoring.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Kepler University Clinic

Linz, Austria

Location

Christian Doppler Klinik

Salzburg, Austria

Location

Motol University Hospital

Prague, Czech Rebuplic, Czechia

Location

Brno Epilepsy Center

Brno, Czech Republic, Czechia

Location

Danish Epilepsy Center

Dianalund, DK 4293, Denmark

Location

Freiburg University

Freiburg im Breisgau, Baden-Wurttemberg, Germany

Location

Carlo Besta Institure

Milan, Italy

Location

Valencia University Hospital

Venice, Italy

Location

Centro Hospitalar e Universitário de Coimbra

Coimbra, Portugal

Location

Hospital de Santa Maria

Lisbon, Portugal

Location

University Hospital Bucharest

Bucharest, Romania

Location

Hospital del Mar

Barcelona, 08003, Spain

Location

Related Publications (8)

  • Boon P, D'Have M, Vanrumste B, Van Hoey G, Vonck K, Van Walleghem P, Caemaert J, Achten E, De Reuck J. Ictal source localization in presurgical patients with refractory epilepsy. J Clin Neurophysiol. 2002 Oct;19(5):461-8. doi: 10.1097/00004691-200210000-00009.

    PMID: 12477991BACKGROUND
  • Brodbeck V, Spinelli L, Lascano AM, Wissmeier M, Vargas MI, Vulliemoz S, Pollo C, Schaller K, Michel CM, Seeck M. Electroencephalographic source imaging: a prospective study of 152 operated epileptic patients. Brain. 2011 Oct;134(Pt 10):2887-97. doi: 10.1093/brain/awr243.

    PMID: 21975586BACKGROUND
  • Beniczky S, Lantz G, Rosenzweig I, Akeson P, Pedersen B, Pinborg LH, Ziebell M, Jespersen B, Fuglsang-Frederiksen A. Source localization of rhythmic ictal EEG activity: a study of diagnostic accuracy following STARD criteria. Epilepsia. 2013 Oct;54(10):1743-52. doi: 10.1111/epi.12339. Epub 2013 Aug 14.

    PMID: 23944234BACKGROUND
  • Megevand P, Spinelli L, Genetti M, Brodbeck V, Momjian S, Schaller K, Michel CM, Vulliemoz S, Seeck M. Electric source imaging of interictal activity accurately localises the seizure onset zone. J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):38-43. doi: 10.1136/jnnp-2013-305515. Epub 2013 Jul 30.

    PMID: 23899624BACKGROUND
  • Rikir E, Koessler L, Gavaret M, Bartolomei F, Colnat-Coulbois S, Vignal JP, Vespignani H, Ramantani G, Maillard LG. Electrical source imaging in cortical malformation-related epilepsy: a prospective EEG-SEEG concordance study. Epilepsia. 2014 Jun;55(6):918-32. doi: 10.1111/epi.12591. Epub 2014 Apr 4.

    PMID: 24702598BACKGROUND
  • Lascano AM, Perneger T, Vulliemoz S, Spinelli L, Garibotto V, Korff CM, Vargas MI, Michel CM, Seeck M. Yield of MRI, high-density electric source imaging (HD-ESI), SPECT and PET in epilepsy surgery candidates. Clin Neurophysiol. 2016 Jan;127(1):150-155. doi: 10.1016/j.clinph.2015.03.025. Epub 2015 May 9.

    PMID: 26021550BACKGROUND
  • Maliia MD, Meritam P, Scherg M, Fabricius M, Rubboli G, Mindruta I, Beniczky S. Epileptiform discharge propagation: Analyzing spikes from the onset to the peak. Clin Neurophysiol. 2016 Apr;127(4):2127-33. doi: 10.1016/j.clinph.2015.12.021. Epub 2016 Jan 12.

    PMID: 26818882BACKGROUND
  • Mouthaan BE, Rados M, Barsi P, Boon P, Carmichael DW, Carrette E, Craiu D, Cross JH, Diehl B, Dimova P, Fabo D, Francione S, Gaskin V, Gil-Nagel A, Grigoreva E, Guekht A, Hirsch E, Hecimovic H, Helmstaedter C, Jung J, Kalviainen R, Kelemen A, Kimiskidis V, Kobulashvili T, Krsek P, Kuchukhidze G, Larsson PG, Leitinger M, Lossius MI, Luzin R, Malmgren K, Mameniskiene R, Marusic P, Metin B, Ozkara C, Pecina H, Quesada CM, Rugg-Gunn F, Rydenhag B, Ryvlin P, Scholly J, Seeck M, Staack AM, Steinhoff BJ, Stepanov V, Tarta-Arsene O, Trinka E, Uzan M, Vogt VL, Vos SB, Vulliemoz S, Huiskamp G, Leijten FS, Van Eijsden P, Braun KP; E-PILEPSY consortium. Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe. Epilepsia. 2016 May;57(5):770-6. doi: 10.1111/epi.13347. Epub 2016 Mar 25.

    PMID: 27012361BACKGROUND

MeSH Terms

Conditions

Drug Resistant EpilepsyHypersensitivity

Condition Hierarchy (Ancestors)

EpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesImmune System Diseases

Study Officials

  • Ricardo Rocamora, MD

    Hospital del Mar

    PRINCIPAL INVESTIGATOR
  • Martin Pali, MD

    Brno Epilepsy Center

    PRINCIPAL INVESTIGATOR
  • Ioana Mindruta, MD

    University Hospital Bucharest (Adult)

    PRINCIPAL INVESTIGATOR
  • Andreas Schulze Bonhage, MD

    Freiburg University

    PRINCIPAL INVESTIGATOR
  • Tim von Oertzen, MD

    Kepler University Clinic, Linz

    PRINCIPAL INVESTIGATOR
  • Vdym Gnatkovsky, MD

    Carlo Besta Institure, Milano

    PRINCIPAL INVESTIGATOR
  • Peter Marusic, MD

    Motol University Hospital

    PRINCIPAL INVESTIGATOR
  • Markus Leitinger, MD

    Christian Doppler Klinik, Salzburg

    PRINCIPAL INVESTIGATOR
  • Francisco Sales, MD

    Unidade Local de Saúde de Coimbra, EPE

    PRINCIPAL INVESTIGATOR
  • vicente villanueva, MD

    Valencia University Hospital

    PRINCIPAL INVESTIGATOR
  • Carla Bente, MD

    Hospital de Santa Maria,

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: Evaluation of automated electrical source imaging(ESI) in epilepsy surgery.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 30, 2019

First Posted

January 6, 2020

Study Start

March 12, 2019

Primary Completion

May 1, 2021

Study Completion

December 31, 2024

Last Updated

February 2, 2024

Record last verified: 2024-02

Locations